Detection frequency and duration of circulating antiphospholipid syndrome markers in patients with verified COVID-19 | Mikhailova | Obstetrics, Gynecology and Reproduction

Obstetrics, Gynecology and Reproduction
Akuserstvo, Ginekologia i Reprodukcia

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)

eng | рус

Preview

Obstetrics, Gynecology and Reproduction

Advanced search

Archives

Download this PDF file

For citations:

Mikhailova Yu.V., Chepurchenko N.V., Obriadina A.P. Detection frequency and duration of circulating antiphospholipid syndrome markers in patients with verified COVID-19. Obstetrics, Gynecology and Reproduction. 2024;18(2):180-187. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.504

Views PDF (Rus): 185

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Makatsariya A.D.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

Yu. V. Mikhailova
RPC Diagnostic Systems Ltd
Russian Federation

Yulia V. Mikhailova, MD, PhD (Biology), Editor-in-Chief, Head of the Department

Editorial and Publishing Department

603093; 22 Yablonevaya Str.; Nizhny Novgorod

N. V. Chepurchenko
RPC Diagnostic Systems Ltd
Russian Federation

Natalia V. Chepurchenko, MD, Microbiologist

New Technologies Implementation Department

603093; 22 Yablonevaya Str.; Nizhny Novgorod

A. P. Obriadina
RPC Diagnostic Systems Ltd
Russian Federation

Anna P. Obriadina, MD, Dr Sci Biol, Deputy Director General

603093; 22 Yablonevaya Str.; Nizhny Novgorod

Notifications